Main Articles Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial

Ross, S.; Thamer, C.; Cescutti, J.; Meinicke, T.; Woerle, H. J.; Broedl, U. C.

Download Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial article for free from OceanOfPDF

Request Code : Z-LIBIO300869

Date:

13 may, 2015

Issue Number:

Issue Volume:

DOI:

10.1111/dom.12469

Issue First Page :

699

Issue Last Page :

702